Bayer, Johnson and Johnson's heart drug Xarelto fails trial to widen use Ruby Khatun Khatun28 Aug 2018 4:15 AM GMTFRANKFURT: Bayer and Johnson and Johnson's campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential...
NPPA notifies prices of 65 essential formulations Ruby Khatun Khatun19 Dec 2017 11:41 AM GMTNew Delhi: National drug pricing regulator NPPA said it has notified prices of 65 essential formulations, including those used for the treatment of...
Lupin gets USFDA nod to market anti-infections tablets Ruby Khatun Khatun12 Sep 2017 4:51 AM GMTNew Delhi: Drug firm Lupin has received approval from the US health regulator to market its generic Doxycycline hyclate tablets, used for the...